1. Home
  2. DSS vs CNSP Comparison

DSS vs CNSP Comparison

Compare DSS & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSS
  • CNSP
  • Stock Information
  • Founded
  • DSS 1984
  • CNSP 2017
  • Country
  • DSS United States
  • CNSP United States
  • Employees
  • DSS N/A
  • CNSP N/A
  • Industry
  • DSS Containers/Packaging
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • DSS Consumer Discretionary
  • CNSP Health Care
  • Exchange
  • DSS Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • DSS 7.3M
  • CNSP 6.5M
  • IPO Year
  • DSS N/A
  • CNSP 2019
  • Fundamental
  • Price
  • DSS $0.85
  • CNSP $0.09
  • Analyst Decision
  • DSS
  • CNSP Strong Buy
  • Analyst Count
  • DSS 0
  • CNSP 1
  • Target Price
  • DSS N/A
  • CNSP $0.50
  • AVG Volume (30 Days)
  • DSS 19.0K
  • CNSP 12.3M
  • Earning Date
  • DSS 03-26-2025
  • CNSP 03-31-2025
  • Dividend Yield
  • DSS N/A
  • CNSP N/A
  • EPS Growth
  • DSS N/A
  • CNSP N/A
  • EPS
  • DSS N/A
  • CNSP N/A
  • Revenue
  • DSS $25,019,000.00
  • CNSP N/A
  • Revenue This Year
  • DSS N/A
  • CNSP N/A
  • Revenue Next Year
  • DSS N/A
  • CNSP N/A
  • P/E Ratio
  • DSS N/A
  • CNSP N/A
  • Revenue Growth
  • DSS N/A
  • CNSP N/A
  • 52 Week Low
  • DSS $0.77
  • CNSP $0.08
  • 52 Week High
  • DSS $2.30
  • CNSP $12.75
  • Technical
  • Relative Strength Index (RSI)
  • DSS 48.09
  • CNSP 37.39
  • Support Level
  • DSS $0.77
  • CNSP $0.09
  • Resistance Level
  • DSS $0.97
  • CNSP $0.10
  • Average True Range (ATR)
  • DSS 0.08
  • CNSP 0.01
  • MACD
  • DSS 0.01
  • CNSP -0.00
  • Stochastic Oscillator
  • DSS 45.45
  • CNSP 26.90

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: